| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||||
2,440 | 5,827 | 6,196 | 5,349 | 4,846 | 3,333 | 0 | 0 | 0 |
Adjustments to reconcile earnings to net cash provided by operating activities: | ||||||||
Depreciation, Depletion and Amortization | ||||||||
3,433 | 3,391 | 3,320 | 3,275 | 3,262 | 3,246 | 0 | 0 | 0 |
Deferred income tax (recovery)/expense | ||||||||
8 | 1,156 | 886 | 989 | 434 | -148 | 0 | 0 | 0 |
Unrealized Gain (Loss) on Derivatives | ||||||||
-343 | 1,751 | 421 | 758 | -105 | -903 | 0 | 0 | 0 |
Earnings from equity investments | ||||||||
-1,253 | -1,503 | -1,592 | -1,637 | -1,587 | -1,509 | 0 | 0 | 0 |
Distributions from equity investments | ||||||||
1,766 | 1,804 | 1,891 | 1,714 | 1,685 | 1,539 | 0 | 0 | 0 |
Equity Method Investment, Other than Temporary Impairment | ||||||||
0 | - | - | - | 0 | - | - | - | - |
Impairment of long-lived assets | ||||||||
- | - | - | - | - | 1,104 | 0 | 0 | 0 |
Other | ||||||||
-279 | -56 | -42 | -18 | -44 | -92 | 0 | 0 | 0 |
Changes in operating assets and liabilities | ||||||||
-602 | 259 | 479 | 1,364 | 374 | -915 | 0 | 0 | 0 |
Net cash provided by operating activities | ||||||||
10,031 | 9,398 | 9,908 | 8,634 | 9,484 | 10,502 | 0 | 0 | 0 |
Investing activities | ||||||||
Capital expenditures | ||||||||
5,027 | 5,492 | 6,150 | 6,348 | 6,783 | 6,806 | 0 | 0 | 0 |
Long-term investments and restricted long-term investments | ||||||||
681 | 1,159 | 1,239 | 1,401 | 1,655 | 1,312 | 0 | 0 | 0 |
Distributions from equity investments in excess of cumulative earnings | ||||||||
355 | 417 | 319 | 405 | 1,359 | 1,277 | 0 | 0 | 0 |
Additions to intangible assets | ||||||||
243 | 200 | 185 | 215 | 308 | 540 | 0 | 0 | 0 |
Affiliate loans, net | ||||||||
274 | 314 | 258 | 216 | 150 | 76 | 0 | 0 | 0 |
Net cash (used in)/provided by investing activities | ||||||||
-3,780 | -4,658 | -4,974 | -3,335 | -3,097 | -3,017 | 0 | 0 | 0 |
Financing activities | ||||||||
Net change in short-term borrowings | ||||||||
-36 | -127 | 21 | -95 | -131 | -420 | 0 | 0 | 0 |
Net change in commercial paper and credit facility draws | ||||||||
-789 | 825 | 3,467 | 3,925 | 982 | -2,256 | 0 | 0 | 0 |
Debenture and term note issues, net of issue costs | ||||||||
0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
Debenture and term note repayments | ||||||||
4,536 | 4,668 | 3,682 | 4,882 | 5,238 | 4,445 | 0 | 0 | 0 |
Debt extinguishment costs | ||||||||
- | - | - | - | - | - | - | - | 0 |
Contributions from noncontrolling interests | ||||||||
24 | 12 | 11 | 12 | 19 | 24 | 0 | 0 | 0 |
Distributions to noncontrolling interests | ||||||||
284 | 254 | 414 | 532 | 694 | 857 | 0 | 0 | 0 |
Common shares issued | ||||||||
1 | 18 | 22 | 25 | 26 | 21 | 0 | 0 | 0 |
Preference share dividends | ||||||||
389 | 383 | 383 | 381 | 367 | 364 | 0 | 0 | 0 |
Common share dividends | ||||||||
6,128 | 5,973 | 5,706 | 4,963 | 4,202 | 3,480 | 0 | 0 | 0 |
Contributions from redeemable noncontrolling interests | ||||||||
- | - | - | - | - | 70 | 0 | 0 | 0 |
Distributions to redeemable noncontrolling interests | ||||||||
- | - | - | - | - | 325 | 0 | 0 | 0 |
Redemption of preferred shares held by subsidiary | ||||||||
0 | 300 | 510 | 510 | 510 | 210 | 0 | 0 | 0 |
Other | ||||||||
-64 | -71 | -78 | -59 | -48 | -23 | 0 | 0 | 0 |
Net cash provided by/(used in) financing activities | ||||||||
-6,230 | -4,745 | -4,816 | -5,162 | -6,395 | -7,503 | 0 | 0 | 0 |
Effect of translation of foreign denominated cash and cash equivalents and restricted cash | ||||||||
62 | 44 | 28 | 8 | 42 | 68 | 0 | 0 | 0 |
Net increase/(decrease) in cash and cash equivalents and restricted cash | ||||||||
83 | 39 | 146 | 145 | 34 | 50 | 0 | 0 | 0 |